Daxor (DXR) Institutional Ownership → New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad) Free DXR Stock Alerts $9.60 -0.14 (-1.44%) (As of 09:30 AM ET) Add Compare Share Share OwnershipStock AnalysisChartFinancialsHeadlinesOwnershipSEC FilingsStock AnalysisChartFinancialsHeadlinesOwnershipSEC Filings Institutional Ownership Changes (13F Filings) for Daxor (NYSEAMERICAN:DXR)CurrentInstitutional OwnershipPercentage1.38%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1 Get DXR Insider Trade Alerts Want to know when executives and insiders are buying or selling Daxor stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DXR Institutional Buying and Selling by Quarter Ad InvestorPlaceNew crypto project uncovers 2,050% in 65 daysDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. Daxor Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/12/2023Renaissance Technologies LLC15,121$166K0.0%-11.7%0.000% 11/14/2022Renaissance Technologies LLC16,921$224K0.0%-19.9%0.419% 11/10/2022Tower Research Capital LLC TRC 2,214$29K0.0%N/A0.055% 8/13/2022Renaissance Technologies LLC21,121$279K0.0%-5.8%0.524% 8/16/2021Sabby Management LLC97,487$1.03M0.1%-17.9%2.417% 8/13/2021Renaissance Technologies LLC23,921$254K0.0%-4.4%0.593% 2/10/2021Renaissance Technologies LLC25,521$319K0.0%-13.5%0.656% (Data available from 1/1/2016 forward) DXR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DXR shares? During the previous two years, the following institutional investors and hedge funds held shares of Daxor shares: Renaissance Technologies LLC ($166K), Tower Research Capital LLC TRC ($29K).Learn more on DXR's institutional investors. What percentage of Daxor stock is owned by institutional investors? 1.38% of Daxor stock is owned by institutional investors. Learn more on DXR's institutional investor holdings. Which institutional investors have been buying Daxor stock? The following institutional investors have purchased Daxor stock in the last 24 months: Tower Research Capital LLC TRC ($2.21K). How much institutional buying is happening at Daxor? Institutional investors have bought a total of 2,214 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Daxor major shareholders have been selling company stock? The following institutional investors have sold Daxor stock in the last 24 months: Renaissance Technologies LLC ($7.50K). How much institutional selling is happening at Daxor? Institutional investors have sold a total of 7,500 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies: Bionano Genomics Institutional Ownership Pro-Dex Institutional Ownership Xilio Therapeutics Institutional Ownership NextCure Institutional Ownership Milestone Scientific Institutional Ownership EUDA Health Institutional Ownership Rafael Institutional Ownership Aadi Bioscience Institutional Ownership CalciMedica Institutional Ownership Bolt Biotherapeutics Institutional Ownership This page (NYSEAMERICAN:DXR) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.